Other

Cumulative amount of fair value hedging adjustment

Pfizer Cumulative amount of fair value hedging adjustment decreased by 52.1% to -$248.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_hedged_liability_fair_value_hedge_cumulative_incre_c9d377

Historical Data

2 periods
 Q4 '25Q1 '26
Value-$163.00M-$248.00M
QoQ Change—-52.1%
Range-$248.00M – -$163.00M

Cumulative amount of fair value hedging adjustment at Other Companies

Merck & Co. logo
Merck & Co.MRKView metric
Amgen logo
AmgenAMGNView metric

Frequently Asked Questions

What is Pfizer's cumulative amount of fair value hedging adjustment?
Pfizer (PFE) reported cumulative amount of fair value hedging adjustment of -$248.00M in Q1 2026.